MeSH D006212 - hallucinations
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D010468:Perceptual disorders
0 Companies
0 Drugs
Success rate
D006212:
Hallucinations
D000075562:Charles bonnet syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Acadia Pharmaceuticals | Pimavanserin | Nuplazid | 2022-07-27 | 2016-04-29 |
Clinical Trials
Historical Success Rate
Phase 1
0%0/2
Phase 2
0%0/3
Phase 3
20%1/5
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use